Trial · NCT01455012
Results by group58
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 58
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in the Number of Elevations of Systolic Blood Pressure (BP) During the Night That Are Associated With Periodic Limb Movements (PLMs) at the End of the 4-week Maintenance Period | Placebo | -79.61 | 95% Confidence Interval 189.3 | Nocturnal Elevations of Systolic BP | |
| Change From Baseline in the Number of Elevations of Systolic Blood Pressure (BP) During the Night That Are Associated With Periodic Limb Movements (PLMs) at the End of the 4-week Maintenance Period | Rotigotine | -239.95 | 95% Confidence Interval 237.1 | Nocturnal Elevations of Systolic BP | |
| Change From Baseline in the Total Number of Elevations of Systolic Blood Pressure (BP) During the Night at the End of the 4-week Maintenance Period | Placebo | -34.3 | Standard Deviation 243.4 | Nocturnal Elevations of Systolic BP | |
| Change From Baseline in the Total Number of Elevations of Systolic Blood Pressure (BP) During the Night at the End of the 4-week Maintenance Period | Rotigotine | -199.8 | Standard Deviation 262.8 | Nocturnal Elevations of Systolic BP | |
| Change From Baseline in the Periodic Limb Movements Index (PLMI) at the End of the 4-week Maintenance Period | Placebo | -15.2 | Standard Deviation 50.3 | Periodic Limb Movements/hour | |
| Change From Baseline in the Periodic Limb Movements Index (PLMI) at the End of the 4-week Maintenance Period | Rotigotine | -50.1 | Standard Deviation 44.5 | Periodic Limb Movements/hour | |
| Change From Baseline in the International Restless Legs Syndrome Rating Scale (IRLS) at the End of the 4-week Maintenance Period | Placebo | -12.5 | Standard Deviation 9.0 | units on a scale | |
| Change From Baseline in the International Restless Legs Syndrome Rating Scale (IRLS) at the End of the 4-week Maintenance Period | Rotigotine | -18.5 | Standard Deviation 8.0 | units on a scale | |
| Change From Baseline in Restless Legs Syndrome-Quality of Life (RLS-QoL) at the End of the 4-week Maintenance Period | Placebo | -11.0 | Standard Deviation 11.9 | units on a scale | |
| Change From Baseline in Restless Legs Syndrome-Quality of Life (RLS-QoL) at the End of the 4-week Maintenance Period | Rotigotine | -17.8 | Standard Deviation 13.2 | units on a scale | |
| Clinical Global Impressions (CGI) Item 2 (Change of Condition) at the End of the 4-week Maintenance Period | Placebo | Very much improved | 9 | participants | |
| Clinical Global Impressions (CGI) Item 2 (Change of Condition) at the End of the 4-week Maintenance Period | Rotigotine | Very much improved | 26 | participants | |
| Clinical Global Impressions (CGI) Item 2 (Change of Condition) at the End of the 4-week Maintenance Period | Placebo | Much improved | 9 | participants | |
| Clinical Global Impressions (CGI) Item 2 (Change of Condition) at the End of the 4-week Maintenance Period | Rotigotine | Much improved | 7 | participants | |
| Clinical Global Impressions (CGI) Item 2 (Change of Condition) at the End of the 4-week Maintenance Period | Placebo | Minimally improved | 4 | participants | |
| Clinical Global Impressions (CGI) Item 2 (Change of Condition) at the End of the 4-week Maintenance Period | Rotigotine | Minimally improved | 3 | participants | |
| Clinical Global Impressions (CGI) Item 2 (Change of Condition) at the End of the 4-week Maintenance Period | Placebo | No change | 6 | participants | |
| Clinical Global Impressions (CGI) Item 2 (Change of Condition) at the End of the 4-week Maintenance Period | Rotigotine | No change | 1 | participants | |
| Clinical Global Impressions (CGI) Item 2 (Change of Condition) at the End of the 4-week Maintenance Period | Placebo | Minimally worse | 1 | participants | |
| Clinical Global Impressions (CGI) Item 2 (Change of Condition) at the End of the 4-week Maintenance Period | Rotigotine | Minimally worse | 0 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01455012/results